- Dec 6, 2019, New Technique to Seal Negative Pressure Wound Therapy on Exposed Dermis | HBOT for Decompression Illness and Arterial Gas Embolism - What's New? Version: 3.2 Ref: 936 Owner: Kerry Carmichael Page 4 of 28 Issued: 8.12.2022 Title: Wound Management Formulary (Adults) and Guidance Document 1. 4 0 obj
DRESSINGS FORMULARY 2020 - Swansea Bay University Health Board <>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/Annots[ 20 0 R 21 0 R] /MediaBox[ 0 0 612 792] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>>
Budget Review 2021/22 2025/26 - Finance & Performance Scrutiny Panel 5th November 2020, Maternity services principles checklist for the care of pregnant women arriving from Afghanistan. Antimicrobial Newsletters; PCE Bulletins; Medicines Management Newsletters. WoundReference allows you to easily share your formulary - share a link one time only and the other institutions would be able to always see the current version of your formulary within WoundReference. | HBOT Patient Educationy, Investigational/Off-Label HBOT Indications | Peer-reviewed Diabetes Foot Ulcer Patient Education in English and Spanisy, Connecting with Patients: Peer-reviewed Wound Care and HBOT Patient Education in English and Spanish, 5 Digital Tools for Patient Education in Wound Care and HBOT | Telehealth Updatesh, When and How to Dismiss a Patient from a Wound and Hyperbaric Center | HBOT and Congestive Heart Failure, Mastering Debridement in Wound Management | Creating and Maintaining Safety in Hyperbaric Facilitiese, Simplifying Wound Care and HBOT Product Choices | Radiation-Induced Cutaneous Damage Updates. PDF Wound Care Formulary Wirral Community NHS Foundation Trust 2020 GGC Medicines: Non- medicines Formularies The wound care formulary companion and guide provides clinical staff with comprehensive information on wound healing and wound care products. Available at: https://woundcareadvisor.com/how-to-set-up-an-effective-wound-care-formulary-and-guideline_vol2-no4/ [Accessed: 10 April 2018]. The wound assessment must be completed by a registered nurse or other healthcare professional. Z#hHp0f"z0)Nbo#93VgGXpK0"0
-w'JZ^s[^g7[YO8a0(%JqA9H$l
VsZn(=I}|.w'
]iA.IH6'HYW2V%Cmg/K6MJAn96+Q_YD^XFL[CmeqZx{xZYVN6sK))B`2P$O
J&?2mQ0!k_a~0Kj!Ru\8n +X66``9?+r
*Q"]L+]%NF~:.SVGs_jOuu\.k Setting up and/or optimizing a good wound care product formulary will save financial and human resources, decrease waste and reduce total treatment cost per episode of care for the following reasons.[1]. Pan Dorset Wound Care Formulary . ?&)]1> qaq\\WP}#s
?4]M5~6(7O[ y+WGE.g*`& [2], Hold a product demonstration session to show clinicians how to use products on the formulary. 43fi)CU;AQTQhdiqe\[$ In that way, if you eventually change product brand in that product type, you dont have to obtain a new order. <>
Limb Preservation: Step-by-Step | Skin Failure or Pressure Injury? 4 Wirral Community NHS Trust Wound Care July 2020 Alginate Kaltostat is a sterile, non-woven calcium alginate dressing. professionals from primary care and secondary care. Save Time When Educating Patients | Telemedicine/ TeleVisits Implementation Playbook Part 1 - Nov 1, 2019, Is Adjunct HBOT Effective for Inflammatory Bowel Disease? Advantage Surgical and Wound Care was established in 2007 by Dr. Robert Marriott and now has grown from a handful of client nursing facilities in Southern California to over 700 across the U.S. today. The goal is for them to become familiar with the options and avoid ordering products that are not part of the formulary [2]. ?[xmW"/[t82vvV[tvur(9bsV/f?I[4(2y-nQtQ2C
j(Hto&OQ FfN@jb-,CWE/iQT@:@?ls5[/*8pq,QsiLg7+WPJMC`2fb{>i#HEeGy6!i"b'Z+;X0{oS1+x|G1I 4c?1\j6TT(Oy,xOJN8'RL*?^0WS!0 Kv ~lm S-K%G2k3
tKP8Z*RqcK=C%)e`. B"S?VJXZ
o xAGTXQ(/\//UaU9?el&#'F@%T[g@j2'%X)
@k^&mgfi)UF- io>K7S`a*
M m+RR89t`Fv2_JwH`m[~ u4 az P9DeFOD|JDOmUT*l6q5Ni:Q3 QSeN ;T%!CeUf:vB Quick Reference Dressings Guide August 2020 update . PDF Quick Reference Dressings Guide August 2020 update - Somerset CCG be used in line with local policy/guidelines. If you would like to add a product to your formulary that is currently not featured on WoundReference, please contact editors@woundreference.com, so that our editorial team can do the research for you and add the product to the. J Dtsch Dermatol Ges 2(2): 89-95 Carry on browsing if youre happy with this or read more about our cookie policy and privacy policy. These leaders are the ones who will create engagement, change practice and lead the team when creating the formulary and directly improve patient care by driving clinical practice decision making. endobj
Updated results showed a 36% decrease in the number of products utilized by the facility (67 to 43 across 22 types), 38.73% decrease in the monthly average . If you already have an existing formulary, you can replicate it within WoundReference so that you can confirm your products are serving your facility well. Woundcare Guide 2020 The guide was developed and published by NCH&C Tissue Viability Nurses. | Wound Care ICD-10 Coding, Coding and Reimbursement Guidelines for Wound Care | 2020 ICD-10 Codes for Wound Care: Updates and Interactive Tool, Reducing Errors and Liability in Wound Care | ICD-10 Codes: 2020 Updates and Interactive Tool for Wound Care Professionals, Defining Your Wound Care Program's Scope of Service | Transfer of Post-operative Care to the Wound Clinic, How to Perform Conservative Sharp Wound Debridement: Protocols, Troubleshooting, Reimbursement | Digital Formulary, Post-operative Care by Wound Services: Getting Reimbursed | Is Adjunct HBOT Effective for Female Infertility? <>
Wound Care Formulary Guidelines - August 2020 FINAL Wales NHS, UK Wound Dressing Formulary [Online]. may result inmore than 38% savings in inventory costs and increased staff efficiency. 2: Cardiovascular System. - Nov 9, 2019, "Can I Shower?" Furthermore, clinicians frequently order products by brand name, not realizing the clinic already has similar products in stock, under a different brand name. <>
0000011587 00000 n
Wound Care Formulary; Newsletters & Publications. Chapters > 0000055698 00000 n
If you need to eliminate or add some brands to each product type, ask your team: What makes a product worth including in your formulary? PDF NHS Greater Glasgow and Clyde Wound Formulary - GGC Medicines Wound Care Formulary | NI Formulary - HSCNI Version 1 produced by JWFG 2018, Reviewed by JWFWG October 2020, Version 2 Approved at DMAG Nov 2020, Next review Nov 2022 Melolin/Melolite Biatain Silicone Lite (Melolite only available to secondary care via UrgoTul Absorb +/ Zetuvit Plus How to Apply Unna Boot - Tips, Techniques & Reimbursement | HBOT for Carbon Monoxide Poisoning - What's New? Protease modulating matrix . Antimicrobial Octenilin Wound Gel (20 per pack) 20ml pods 350-8975 1 Amber Antimicrobial Prontosan Pods (24 x 40ml pods) 40ml 374-5940 1 Amber . Factors to consider are: Once you answered the questions above and defined your resources, needs and limitations, follow the steps below: After you set up your formulary within WoundReference, all users under your Organization will automatically have access to it. Increasing HBOT Referrals | Skin Essentials & Principles of Wound Healing | A Peek Into 2021 CMS Reimbursement, Skin Essentials | A Peek Into 2021 CMS Reimbursement, Patient Education For Successful Wound Care TeleVisits | Wound and HBOT Digital Tools Poster Gallery | Network With Colleagues, HBOT for Gas Gangrene CME/CE/Category A | Patient Education For Successful Wound TeleVisits | Wound and HBOT Digital Tools Poster Gallery, Telehealth Beyond COVID-19: Transforming Best Practice in Wound Care | HBOT for Compromised Grafts and Flaps, Updates and resources for wound care & HBOT during COVID-19 and beyond | Surgical Ostomies, WoundReference offers clinicians free use of the TeleVisit Tool, Offloading solved: how to select offloading devices for DFUs, Webinar - Unwrapping Venous Leg Ulcers (free CNE) | Offloading Devices - Evidence, Practice, Reimbursement | HBOT Category A Credits, More Online, Self-Paced Hyperbaric Category A Continuing Education | No More Tears Part 2 - Skin Tears Treatment and Prevention, Online, Self-Paced Hyperbaric Category A Continuing Education | Nutrition for Wound Healing - Patient Education. What features are important for each product type? MMT & supports the implementation of formulary choices contained in the Somerset Wound Formulary. INTRODUCTION This Wound Management Formulary and guidance document is designed to support clinicians employed by CHCP CIC in their assessment and management of wounds by ensuring that their choice 0000006469 00000 n
0000009522 00000 n
We believe in strength of global idea sharing and the power of education, so we work and develop the ReadkonG to help people all over the world to find the answers and share the ideas they are interested in. This formulary will assist clinical staff in a variety of settings including GP Practices, nursing homes . Bedfordshire & Luton Wound Care Formulary Requests. [2], Train clinicians on how to use the formulary and guidelines. %PDF-1.7
0000010998 00000 n
startxref
5479 28
1 0 obj
We have previously shown that implementation of a local wound care formulary may result inmore than 38% savings in inventory costs and increased staff efficiency. The goal of a wound care product formulary is to help all healthcare professionals who care and treat patients with wounds select the most appropriate dressings and bandages for each patient. Wound Management (Dressings) Formulary - Gloucestershire Hospitals NHS Connect with a Smith+Nephew representative to customise the WOUND COMPASS CSA to your formulary today. Applications are required to make . PDF Staffordshire and Stoke-on-Trent Woundcare Dressings Formulary Updated hb```f``d`a` @ 8p{M @Q[=;;+;L+ ^;@$ 66vuj3;2Qme({|47iwiF ~` |)
Adult Primary Care Antibiotic Guidelines; Paediatric Primary Care Antibiotic Guidelines; Fosfomycin - prescribing and supply; Penicillin allergy; Guidance on the Management of Proven or Suspected Staph. The ultimate telehealth solution is here. hn6_ ]g7yWYoH8 17. | Teaching About Chronic Wounds, 2021 Coding & Billing Toolkit for HBOT and Wound Care, Telehealth Evidence and Best Practices | 2021 Reimbursement and Quality Updates, HBOT for diabetic foot ulcers | Wound Care Billing Essentials | Patient-centered Telehealth, What's New? Can we add product brands that are used by other institutions we refer patients to? - Nevada Medicaid, Guidelines for oral health services at COVID-19 Alert Level 2 - 11 May 2020, Beaumont Lodge Transitional Care Unit - Patient Information Booklet Care you can trust - Bartra Healthcare, Business Plan 2021-25 - Our Global Challenge - Primary Care International. other healthcare professional. |X
-Q4zLh0Z8j!%F6U0Ta E1C /eRS",ZxfQ(4.F2Ei
Yyjs [6(! As a result, expected dressings outcomes will be achieved, with less product waste. How to set up an effective wound care formulary and guideline - Wound Care Advisor [Online]. Clinicians who are respected leaders and possess command of product usage/costs can serve as clinician champions to lead the change and facilitate the meetings. hbbd```b``z"
u%Dr0Hc m&^m0F-H2+X^jDg;@ It will help clinicians use products from the formulary (see templates) [2], Educate clinicians to write orders by product type instead of brand name (e.g., alginate dressing as opposed to 3M Tegaderm Superabsorber dressing) and have a field to indicate which product brand the clinician should use. . endobj
WoundReference Digital Formulary: Local Wound Care Formularies Made Easy 0000089420 00000 n
0000008106 00000 n
Preferred Drug Lists (PDL) | MaineCare PDL 0000009268 00000 n
: Click on the following link to access the Gloucestershire Wound Management Formulary, Includes approved dressings and appliances, Nurse Formulary Order Form: https://ccglive.glos.nhs.uk/intranet/index.php/ccg-strategy/medicines-management/formularies/glos-dressing-formulary. Available at: http://www.wales.nhs.uk/sitesplus/documents/862/FOI-101b.pdf [Accessed: 5 April 2018]. <]/Prev 376811/XRefStm 1838>>
person-centred approach to care should be considered at all times. share this article with the institution you work with, Request for Non-Formulary Wound Care Product. 7: Obstetrics, gynaecology & urinary tract disorders, 17: Wound Management (Dressings) Formulary, 18: Continence and Urology Products (Adults), NICE Technology Appraisals / Highly Specialised Technologies Guidance, Join our Foundation Trust today and support our hospitals. Important: Only the version of this document available from . Includes approved dressings and appliances. an updated tool to address the current challenges in wound care 2019 . 0000010187 00000 n
endstream
endobj
startxref
. NHS Fife: Area Drugs and Therapeutics Committee, Paediatric Primary Care Antibiotic Guidelines, Guidance on the Management of Proven or Suspected Staph. The wound care formulary has been developed to reduce unwanted variation and cost. 0000010736 00000 n
Working together. The 3 C's - Chronic Wounds | COVID-19 | CROM, Arterial Ulcer Series | Wound Care Modules | Advanced Practice Providers & HBOT. The wound assessment must be completed by a registered nurse or
Wound Care Management Formulary Amendment History VERSION DATE AMENDMENT HISTORY 4.0 December 2014 Previous version 5.0 September 2015 Comments - Additional products added and . endobj
PDF NHS Grampian Joint Wound Care Formulary Summary Chart of Formulary The wound care formulary has been developed to reduce unwanted variation and cost. 0000002102 00000 n
Antibacterial preparations also used systemically, 13.11 Skin cleansers, antiseptics, and desloughing agents, Cost Effective Choices and Switching PILs, Generic Prescribing Newsletters and Exception List, Swallowing Difficulties & Thickening Agents, Allow extra time when ordering your prescription. PDF Wound Formulary - GP Portal Wound Care Today - Article: Differentiating between cellulitis This document supersedes any previous community (Islington and Haringey) and hospital wound care formulary. 3: Respiratory System. endstream
endobj
1114 0 obj
<>/Metadata 25 0 R/Pages 1111 0 R/StructTreeRoot 37 0 R/Type/Catalog>>
endobj
1115 0 obj
<>/MediaBox[0 0 841.92 595.32]/Parent 1111 0 R/Resources<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI]/XObject<>>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>>
endobj
1116 0 obj
<>stream
Intra-uterine progestogen-only device, 7.3.6 Delaying Menstruation During Holidays, 7.4.1 Drugs for voiding (obstructive) symptoms in men, 7.4.2 Drugs for urinary frequency, enuresis, and incontinence, 8.0 Malignant Disease and Immunosuppression, 9.1 Anaemias and some other blood disorders, 9.1.2 Drugs used in megaloblastic anaemias, 9.4.1 Step 1-Identification of nutritional risk, 9.4.2-Step 2-Underlying causes of malnutrition, 9.4.4-Step 4-Discuss Food First dietary advice, Supplementations in pregnancy/ pre-conception, 10.1 Drugs use in rheumatic diseases and gout, 10.1.3 Drugs that suppress the rheumatic disease process, 10.1.4 Gout and cytotoxic-induced hyperuricaemia, 10.1.5 Other drugs for rheumatic diseases, 10.2 Drugs used in neuromuscular disorders, 10.2.1 Drugs that enhance neuromuscular transmission, 10.3 Drugs used for the treatment of soft-tissue disorders and topical pain relief, 10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices, 13.2.1.1 Emollient bath and shower preparations, 13.3. 2021 Summary of Benefits - Kaiser Permanente Kaiser Permanente Medicare Advantage (HMO) Group plan Plan C++ with D for persons with Medicare Parts My journey through maternity care - Helping you make decisions about your care - Maternity Voices Partnerships Leeds, ATU and DCU Actives - Portland Public Schools, Private Clinic Set-up Requirements Overview - FSOMA, 2020 State Reinsurance Program Parameters & Plans - John-Pierre Cardenas, Director of Policy and Plan Management, HEALTHCARE INSPECTORATE WALES - Strategic Plan 2018 2021, PRESENTATION OF UNAUDITED FY2017 RESULTS - Arvida Group Limited Year Ended 31 March 2017, T WIS H - REVER - Ambulance Wish Queensland, Antenatal care National Institute for Health and Care Excellence - NCBI, Provider Enrollment Information Booklet - Welcome! ActivHeal AquaFiber Extra 5x5cm 270828 1 x 10 10x10cm 270835 1 x 10 15x15cm 270842 1 x 10 Ribbon 2x46cm 270811 1 x 5 . Applications for dressings to be added to the Formulary are accepted from Practitioners who work in the constituent organisations. For each product selected for your formulary, you can create and save custom notes with product instructions to serve as a staff educational platform and a quick-reference manual. To replicate your formulary within WoundReference and confirm optimal product choice, follow steps described in Setting up your formulary, Pressure Ulcer/Injury Prevention - Taking the Journey Forward, Lymphedema Assessment And Management Updates | Local Wound Care Formularies Made Easy, Enhanced Coding And Billing Toolkit for HBOT and Wound Care, 5 Tools To Streamline Patient Education In Wound Care and HBOT, Building a Successful Antimicrobial Stewardship Program in Wound Care | HBOT and Wound Care Ongoing Competencies. SWFT wound care formulary items have been selected because they are clinically and cost effective New products now available on formulary Biatain Silicone Silicone Foam Biatain Silicone Lite Silicone Foam Biatain Soft-Hold Foam Non-Adhesive PDF Wound Management Formulary (Adults) and Guidance Document Clinician preferences and usage patterns can help you determine baseline usage and costs before implementation of a formulary, and can provide ideas of what products clinicians might be more inclined to accept as being part of the Institutions formulary. | Venous Leg Ulcers Assessment and Management - What's New? 0000007846 00000 n
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care. If you already have an existing formulary, you can replicate it within WoundReference so that you can confirm your products are serving your facility well. Are your patients only seen at your facility or do they get referred to other settings, such as skilled nursing facilities, home health, community health clinics, etc?
OTR~PONB*IHC#pUH5Wc"wb-gPqtr:yPxu`&
L k! 5479 0 obj
<>
endobj
[2]. Prescribing in palliative care. Topical local anaesthetics and antipruretics, 13.4.1 Topical corticosteroids with antimicrobials, 13.5 Preparations for eczema and psoriasis, 13.9 Shampoos and other preparations for scalp and hair conditions, 13.10.1.1. It is an absorbent, haemostatic dressing which forms a viscous gel on contact with wound exudate. Home; Prior Authorization (PA) Forms & Related Info; Preferred Drug Lists (PDL) MaineCare PDL; Additional PDL News & Info; Physician Administered Drugs; Drug Utilization Review; Psychiatric Work Group (PWG) Pain Management; Legislation / Policy; Manufacturer Rebate; x[n7}0OLP6E@6(#W6q"g[&{@$O4!yN<={wnN8E"{zlNpg~Kc##C_mNAh||wC7m|qk=1_bRPh+O+nxC0\. 0000002265 00000 n
Wound Care | NHS East and North Hertfordshire Clinical - enhertsccg Is there a budget for each type of product? Practitioners are expected to use dressings that are listed in the Formulary or to have a valid rationale if another is chosen. To improve transition of care, it is also helpful if you are able to share your Institutions formulary with other services you work with on the healthcare continuum. If you have more than 3, decide which ones to eliminate so you end up with 2-3 per product type. 17. Wound Management Formulary Wound Care Management Formulary A formulary reinforces consistency of product utilization, leading to maximized clinicians application skills. xref
0000007307 00000 n
This wound care formulary companion provides clinical staff with a comprehensive guide to wound dressing products. A holistic person-centred approach to care should be considered at all times. By having products that are clinically proven and cost-effective in the formulary, ad-hoc dressing orders will be can be decreased. wound management practices are standardised across the primary and secondary care settings, and to promote seamless care to patients. The information that you provide will be reviewed by the Wound Formulary Group and will be taken into consideration when the formulary is revised and . CID: 902 Published: September 2013 Last Review: September 2020 Next Review: September 2023 The information relating to each product isPaper copies of this document should be kept to a minimum and checks made with the electronic version to ensure that the printed version is the most recent. If your patients are referred across the continuum of care, try to obtain formularies of the other settings you work with, and consider incorporating product brands they use into your formulary. 6.1 March 2020 Draft revised product inclusion and products removed that have been delisted 7.0 July 2020 Approved by ACE 7.1 April 2021 Draft revised product . 0000005936 00000 n
To facilitate the collaboration, share this article with the institution you work with - it will walk them through how to set up their own formulary within WoundReference and how to share their formulary with you, so that you always have real-time access to the most current version of their formulary within WoundReference. 1113 0 obj
<>
endobj
Woundcare formulary - Fifeadtc.scot.nhs.uk J
0000007040 00000 n
]putU"p&"tiMGEAcPZu8PYaQ\". 0000004715 00000 n
hTYhaVm1Bk4]I(HXT$BAF
x >Vz5B]A. Save Time When Educating Patients | Telemedicine/ TeleVisits Implementation Playbook Part 1, Is Adjunct HBOT Effective for Inflammatory Bowel Disease? This page was printed from the South & West Devon Formulary and Referral site at var d=new Date(); document.write(d); Please ensure you are using the current version of this document, Home > <>/Font<>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.32 841.92] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>>
Click on the following link to access the Gloucestershire Wound Management Formulary. 2.0 27/12/2017 Review of formulary Updated products no longer available with alternatives. 1130 0 obj
<>/Filter/FlateDecode/ID[<12BB5274D465E34DB5B57A64C1CB6DA6><2061A19AF8AE9E4E80ACA00AE3199E71>]/Index[1113 38]/Info 1112 0 R/Length 93/Prev 515504/Root 1114 0 R/Size 1151/Type/XRef/W[1 3 1]>>stream
1.1 Dyspepsia and gastro-oesophageal reflux disease (GORD), 1.1.2 Compound alginates and proprietary indigestion preparations, 1.2 Antispasmodics and other drugs altering gut motility, 1.3 Antisecretory drugs and mucosal protectants, 1.5.1.1 Acute Exacerbation of ulcerative colitis, 1.5.1.2 Maintenance of remission of ulcerative colitis, 1.5.2 Corticosteroids inflammatory bowel disease, 1.5.3 Steroid-sparing treatment for inflammatory bowel disease, 1.7 Local preparations for anal and rectal disorders, 1.7.1 Soothing haemorrhoidal preparations, 1.7.2 Compound haemorrhoidal preparations with corticosteroids, 1.9 Drugs affecting intestinal secretions, 2.2.3 Potassium-sparing diuretics and aldosterone antagonists, 2.2.4 Potassium-sparing diuretics with other diuretics, 2.5.2 Centrally acting antihypertensive drugs, 2.5.5 Drugs affecting the renin-angiotensin system, 2.5.5.1 Angiotensin-converting enzyme inhibitors, 2.5.5.2 Angiotensin-II receptor antagonists (AIIRAs/ARBs), 2.6 Nitrates, calcium-channel blockers and other antianginal drugs, 2.6.4 Peripheral vasodilators and related drugs, 2.8.2.2 Treatment of pulmonary embolism and deep vein thrombosis and prevention of recurrent, 2.8.2.3 Prophylaxis of venous thromboembolism in orthopaedics-specialist use in secondary care only, 2.8.2.5 Prevention of Atherothrombotic events, 2.10 Stable angina, acute coronary syndromes and fibrinolysis, 2.11 Antifibrinolytic drugs and haemostatics, 3.1.4 Compound bronchodilator preparations, 3.1.5 Peak flow meters, inhaler devices and nebulisers, 3.2.1 Single agent inhalers [asthma only], 3.2.2 Compound ICS/LABA preparations [asthma], 3.2.3 Compound ICS/LABA preparations COPD, 3.3 Leukotriene receptor antagonists and phosphodiesterase type-4 inhibitors, 3.3.3 Phosphodiesterase type-4 inhibitors, 3.4 Antihistamines, hyposensitisation and allergic emergencies, 3.4.2 Allergen immunotherapy (desensitisation), 4.2 Drugs used in psychoses and related disorders, 4.2.1.1 Management of agitation and aggression, 4.2.3.1 Treatment of the acute phase of mania, 4.2.3.2 Maintenance treatment of bipolar disorder with mood stabilisers, 4.3.1 Mild, moderate and severe depression, 4.3.2 Antidepressants for the treatment of anxiety disorders*, 4.3.2.1 Generalised anxiety disorder (GAD), social anxiety disorder, 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder, 4.4.2 Attention deficit hyperactive disorder (ADHD) in adults, 4.5 Drugs used in the treatment of obesity, 4.5.1 Anti-obesity drugs acting on the gastro-intestinal tract, 4.6.1 Drugs for the short-term treatment of nausea and vomiting, 4.7.4.1 Treatment of acute migraine attack, 4.7.4.3 Drug treatment of cluster headache, 4.9 Drugs used in parkinsonism and related disorders, 4.9.1 Dopaminergic drugs used in parkinsonism, 4.9.1.3 Monoamine-oxidase-B (MAOB) inhibitors, 4.9.1.4 Catechol-O-methyltransferase inhibitors (COMT inhibitors), 4.9.2 Antimuscarinic drugs used in parkinsonism, 4.9.4 Management of dementia in Parkinsons disease, 4.10 Medications used in substance use disorders, 4.10.3 Benzodiazepine and Z drug withdrawal, 4.10.4.3 Interventions for the reduction of alcohol consumption, 4.11.1 Management of Behavioural and Psychological Symptoms of Dementia (BPSD), 6.1.2.3 Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors), 6.1.2.5 Sodium-glucose co-transporter 2 (SGLT-2) inhibitors, 6.1.6 Diagnostic and monitoring agents for diabetes mellitus, Summary of oral drug treatments for type 2 diabetes, 6.2 Thyroid and antithyroid drugs and parathyroid disease, 6.4.1.1 Hormone replacement therapy (HRT) for menopausal symptoms, 6.4.1.1a Women who have not had a hysterectomy, 6.4.1.1b Women who have had a hysterectomy or who have a Mirena Intra Uterine System (ISU) in situ, 6.5 Pituitary hormones and anti-oestrogens, 6.5.2 Posterior pituitary hormones and antagonists, 6.5.2.2 Antidiuretic hormone antagonists, 6.6.1 Drugs for the treatment and management of osteoporosis, 6.6.1.3 Other drug therapies used in osteoporosis, 7.0 Contraception, Gynaecology and Urinary Tract Disorders, 7.1.3 Endometriosis (previously diagnosed by laparoscopy), 7.2 Treatment of vaginal and vulval conditions, 7.2.1 Preparations for vaginal and vulval changes, Review copy of Review copy of 7.2.2 Vaginal and vulval infections, 7.3.1 Combined hormonal oral contraceptives, 7.3.2.1 Oral progestogen-only contraceptives, 7.3.2.2 Parenteral progestogen-only contraceptives, 7.3.2.3.